Skip to main navigation Skip to search Skip to main content

Angiotensin converting enzyme inhibitors: Inhibition of growth, a novel mechanism of action

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Angiotensin II, a known vasopressor agent, recently has been implicated as a growth factor in the heart and vascular smooth muscle. Angiotensin converting enzyme (ACE) inhibitors, which block angiotensin II synthesis, have been found to prevent or reverse cellular growth in the heart and vasculature—a novel mechanism of action. Further study is required to determine the precise mechanisms through which angiotensin II promotes growth as well as the mechanisms through which ACE inhibitors block growth, Large scale clinical trials are needed to delineate further the effectiveness of ACE inhibitors in humans, especially regarding vascular smooth muscle growth.

Original languageEnglish
Pages (from-to)57-71
Number of pages15
JournalJournal of Cardiovascular Nursing
Volume8
Issue number4
DOIs
StatePublished - 1994

Keywords

  • ACE inhibitors
  • Cardiac hypertrophy
  • Neointimal hyperplasia
  • Pathophysiology
  • Vascular smooth muscle growth

Fingerprint

Dive into the research topics of 'Angiotensin converting enzyme inhibitors: Inhibition of growth, a novel mechanism of action'. Together they form a unique fingerprint.

Cite this